Unichem Laboratories on Friday said inspection of its unit in Kolhapur, Maharashtra, by the US health regulator has been completed without any observations. The company’s newly-commissioned active pharmaceutical ingredients (API) facility was inspected by the United States Food and Drug Administration from September 16 to 20, Unichem Labs said. The CGMP surveillance and pre-approval inspection was successfully concluded without issue of Form 483, it added.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.